Create and manipulate a KINNATE BIOPHARMA (NSQ:KNTE) stock price chart, with moving average, RSI & MACD overlays. Add your portfolio transactions. KNTE Stock Overview. Kinnate Biopharma Inc., a clinical-stage oncology company, focuses on the discovery and development of small molecule kinase inhibitors to. Kinnate Biopharma Insider Activity ; Meltz Mark A, 08/31/, , 28,, ; Krishnamohan Neha, 08/31/, 1,, 67,, Kinnate Biopharma Inc. (US:KNTE) has 26 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Track Kinnate Biopharma Inc (KNTE) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Kinnate Biopharma Inc. (KNTE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Stock price history for Kinnate Biopharma. The week high for Kinnate Biopharma Inc. Stock is $ and the week low is $ With Futu, you can save up to HK$33, annually when trading HK and US stocks. Commission-free HK stock trading does not apply to stock options trading in the. Kinnate Biopharma Inc., a clinical-stage oncology company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically. Kinnate Biopharma Inc is listed in the sector of the NASDAQ with ticker KNTE. The last closing price for Kinnate Biopharma was $ Over the last year. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. According to the 5 analysts' twelve-month price targets for Kinnate Biopharma, the average price target is $ The highest price target for KNTE is $ Kinnate Biopharma Inc. is a clinical-stage precision oncology company. It is focused on the discovery, design and development of small molecule kinase. Kinnate Biopharma Inc. (Nasdaq: KNTE) is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focusing on the discovery and. A high-level overview of Kinnate Biopharma Inc. (KNTE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals.
Kinnate BioPharma Inc. ; $ ; % Last Close; Apr 2, ; Trading Volume, 2,, ; Week High/Low ($); - ; Market Cap Full, $ M. What was Kinnate Biopharma's price range in the past 12 months? Kinnate Biopharma lowest stock price was $ and its highest was $ in the past 12 months. Stifel Raises Kinnate Biopharma's Price Target to $ From $, Keeps Hold Rating · Wedbush Adjusts Kinnate Biopharma's PT to $ From $2 on Heels of. Webull offers Kinnate Biopharma Inc. (KNTE) historical stock prices, in-depth market analysis, NASDAQ: KNTE real-time stock quote data, in-depth charts. How is Kinnate Biopharma' stock traded? We are traded on the NASDAQ Global Select Market under the ticker symbol “KNTE”, and our CUSIP number is R Kinnate Biopharma is a precision oncology company focused on the design and development of selective small molecules targeting genetic mutations and fusions. What Is the Kinnate Biopharma Inc Stock Price Today? The Kinnate Biopharma Inc stock price today is What Is the Stock Symbol for Kinnate Biopharma Inc? Kinnate Biopharma Historic Stock Lookup. ERROR NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock. Kinnate Biopharma Inc. (KNTE). Kinnate Biopharma Inc NASDAQ: KNTE is a biopharmaceutical company focused on the discovery and development of small molecule.
The intrinsic value of one KNTE stock under the Base Case scenario is USD. Compared to the current market price of USD, Kinnate Biopharma Inc is. This stock is no longer active on Robinhood. Sign up for a Robinhood brokerage account to watch KNTE and buy and sell other stock and options commission-free. Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers. Its mission is to expand the reach of. Free KINNATE BIOPHARMA INC COM CVR (vorotv.ru) analysis tools, including analyst ratings and target price forecasts, help you make informed investment. Ratings analysis incomplete due to data availability. Recommendations not provided. Maximize Income Goal. See Best High Dividend Stocks Model Portfolio for our.
Buy Kinnate Biopharma Shares from India at $ (0 Commission) today. Start investing in Kinnate Biopharma stocks from India now with fractional investing. According to Kinnate Biopharma Inc.'s latest financial reports and current stock price. The company's current Current Ratio is This represents a change. Kinnate Biopharma's current share price is $ This constitutes a share price movement of % when compared to its closing share. There are currently no known stock splits for Kinnate Biopharma Inc Ordinary Shares. Did Kinnate Biopharma Inc Ordinary Shares pay a dividend in the past?
Biotech stocks: Which drugmakers are worth a buy?